- ISIN
- US45685K1025
- CUSIP
- 45685K102
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Dec 27, 2007
Highlights
- Market Cap
- $186.37M
- Enterprise Value
- $207.03M
- EPS (TTM)
- $0.38
- PE Ratio
- 23.73
- PEG Ratio
- 0.02
- Total Revenue (TTM)
- $142.40M
- Gross Profit (TTM)
- $80.81M
- EBITDA (TTM)
- $23.03M
- Year Range
- $5.38 - $11.04
- Target Price
- $15.00
- ROA (TTM)
- 8.02%
- ROE (TTM)
- 13.47%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
INFU Performance Chart
InfuSystem Holdings Inc. (INFU) is down 0.6% since the beginning of the year. At $9 per share, INFU is trading 19.2% below its 52-week high of $11. Investors who bought $1,000 worth of INFU shares 5 years ago would now be looking at an investment worth $467.
Loading charts...
Returns By Period
InfuSystem Holdings Inc. (INFU) has returned -0.56% so far this year and 42.72% over the past 12 months. Over the last ten years, INFU has returned 12.95% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
InfuSystem Holdings Inc.
- 1D
- -5.31%
- 1M
- -7.66%
- YTD
- -0.56%
- 6M
- -2.62%
- 1Y
- 42.72%
- 3Y*
- -3.35%
- 5Y*
- -14.12%
- 10Y*
- 12.95%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
INFU Monthly Returns History
Based on dividend-adjusted daily data since Dec 27, 2007, INFU's average daily return is +0.09%, while the average monthly return is +1.58%. At this rate, an investment would double in approximately 3.7 years.
Historically, 48% of months were positive and 52% were negative. The best month was Aug 2025 with a return of +92.5%, while the worst month was Sep 2011 at -37.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.
On a daily basis, INFU closed higher 42% of trading days. The best single day was Mar 26, 2009 with a return of +41.7%, while the worst single day was Nov 7, 2016 at -38.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.92% | 6.17% | 5.25% | 9.75% | -10.46% | -1.65% | -0.56% | ||||||
| 2025 | -4.26% | -1.36% | -32.58% | -12.27% | 22.46% | 7.96% | -10.26% | 92.50% | -3.90% | -0.00% | -10.42% | -3.34% | 6.15% |
| 2024 | -12.43% | 0.22% | -7.35% | -12.37% | -4.93% | -4.34% | 1.02% | -3.62% | 0.75% | -7.61% | 43.78% | -5.06% | -19.83% |
| 2023 | 15.44% | -6.29% | -17.47% | 20.90% | -6.62% | 10.06% | 7.17% | -0.39% | -6.23% | -0.62% | 4.70% | 5.08% | 21.43% |
| 2022 | -11.33% | -23.91% | -14.71% | -19.08% | 21.94% | -0.41% | 1.45% | -21.08% | -9.34% | 9.16% | 12.45% | 1.17% | -49.03% |
| 2021 | -6.18% | -3.18% | 19.34% | 11.10% | -18.21% | 12.38% | -12.22% | -21.92% | -8.56% | 27.63% | -0.48% | 2.90% | -9.32% |
Benchmark Metrics
InfuSystem Holdings Inc. has an annualized alpha of 17.87%, beta of 0.47, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since December 27, 2007.
- This stock participated in 84.55% of S&P 500 Index downside but only 67.81% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.47 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 17.87%
- Beta
- 0.47
- R²
- 0.03
- Upside Capture
- 67.81%
- Downside Capture
- 84.55%
Return for Risk
Risk / Return Rank
INFU ranks 67 for risk / return — better than 67% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for InfuSystem Holdings Inc. (INFU) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INFU | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.37 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.38 | 2.78 | -1.41 |
| Martin ratioReturn relative to average drawdown | 3.11 | 12.44 | -9.33 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the InfuSystem Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the InfuSystem Holdings Inc. was 79.49%, occurring on May 6, 2025. The portfolio has not yet recovered.
The current InfuSystem Holdings Inc. drawdown is 61.08%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -79.49%May 2025 | 4y 3d | — | 5y 1moMay 2021 - now |
2011 bear market2011 | -78.33%Oct 2011 | 3y 8mo | 3y 11d | 6y 8moFeb 2008 - Oct 2014 |
2017 bear market2017 | -69.70%May 2017 | 2y 6mo | 1y 10mo | 4y 4moOct 2014 - Mar 2019 |
COVID crash2020 | -51.49%Mar 2020 | 26d | 1mo | 1mo 26dFeb 2020 - Apr 2020 |
2020 correction2020 | -19.84%May 2020 | 22d | 2mo 25d | 3mo 17dApr 2020 - Aug 2020 |
Drawdown Indicators
| INFU | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.49% | -56.78% | -22.71% |
Max Drawdown (1Y)Largest decline over 1 year | -31.17% | -9.10% | -22.07% |
Max Drawdown (3Y)Largest decline over 3 years | -58.22% | -18.90% | -39.32% |
Max Drawdown (5Y)Largest decline over 5 years | -78.13% | -25.43% | -52.70% |
Max Drawdown (10Y)Largest decline over 10 years | -79.49% | -33.92% | -45.57% |
Current DrawdownCurrent decline from peak | -61.08% | -1.80% | -59.28% |
Average DrawdownAverage peak-to-trough decline | -42.03% | -10.71% | -31.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.79% | 2.03% | +11.76% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of InfuSystem Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how InfuSystem Holdings Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for INFU, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/E ratio of 23.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for INFU compared to other companies in the Medical Instruments & Supplies industry. INFU currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for INFU relative to other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for INFU in comparison with other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/B value of 3.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with INFU
Add InfuSystem Holdings Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with INFU